Home  |  Site Map  |  Glossary  | Contact
Text size: AA   AA   AA

Press Releases

2008 Press Releases
Listed below are all of the QLT press releases available for the year you have selected.

December 16

QLT Announces Interim Results of RADICAL Study Evaluating Visudyne® Combination Therapy

PDF version

December 05

QLT Announces Commencement of Tender Offer

PDF version

December 01

QLT To Repurchase Up to US$50 Million of Common Shares

PDF version

October 28

QLT Announces Encouraging Phase II Data From Core Study of Punctal Plug Drug Delivery System

PDF version

October 28

QLT Announces Third Quarter Results for 2008

PDF version

October 20

QLT Announces Third Quarter 2008 Visudyne® Sales

PDF version

October 09

QLT Announces the Initiation of a Phase I Trial of its Synthetic Retinoid Product

PDF version

September 15

QLT Announces Completion of the Redemption of 3% Convertible Senior Notes Due 2023

PDF version

September 02

QLT Completes CDN$65.5 Million Real Estate Transaction

PDF version

August 26

QLT Announces Agreement to Exclusively License the Atrigel® Technology to Reckitt Benckiser Pharmaceuticals Inc.

PDF version

August 11

QLT Announces Redemption of 3% Convertible Senior Notes Due 2023

PDF version

August 08

QLT Announces Removal of Conditions on CDN$65.5 Million Real Estate Transaction

PDF version

July 29

QLT Announces Second Quarter Results for 2008

PDF version

July 17

QLT Announces Second Quarter 2008 Visudyne® Sales

PDF version

July 14

QLT Completes Divestment of Aczone® to Allergan for USD$150 Million

PDF version

June 09

QLT Announces Agreement to Sell Aczone® to Allergan for Approximately US$150 Million

PDF version

June 06

QLT Announces Positive Health Canada Decision on Aczone®

PDF version

May 15

QLT Inc. Announces Agreement for Sale of Real Estate

PDF version

May 12

QLT Reports Initial Proof-of-Concept Data for Punctal Plug Delivery Technology

PDF version

May 05

QLT Completes Enrollment in the RADICAL Study

PDF version

April 25

QLT Announces First Quarter Results for 2008

PDF version

April 21

QLT Announces First Quarter 2008 Visudyne® Sales

PDF version

March 31

QLT Initiates Phase II Study of Punctal Plug Drug Delivery System for Glaucoma & Ocular Hypertension

PDF version

March 28

Positive Results from Visudyne® Combination Therapy Study Reported at Annual Macula Society Conference

PDF version

March 17

QLT Announces Positive FDA Action on Aczone™

PDF version

February 21

QLT Announces 2007 Results

PDF version

January 18

QLT Reduces Workforce as First Step in its Strategic Restructure

PDF version

January 17

QLT Announces Visudyne® Sales for Fourth Quarter and Fiscal Year 2007

PDF version

January 16

QLT Inc. Announces Initial Steps in Strategic Restructuring

PDF version

Visudyne® is a registered trademark of Novartis AG
 
Copyright 2000-2009 QLT Inc. Legal Terms for use of site and Privacy Policy | Disclaimer
Vancouver Web Design by Graphically Speaking